Skip to content

Fermented barley extract improved lipid profile in patients with hyperlipidemia

Fermented barley extract improved lipid profile in patients with hyperlipidemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019614
Enrollment
Unknown
Registered
2018-11-19
Start date
2018-11-24
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

1:Diet and exercise
2:Diet and exercise and LFBE
3:Diet and exercise and ß-glucan

Sponsors

Affiliated hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 45-70 years old; 2. Body mass index 24-35Kg/m2; 3. Waist circumference: male is equal to 85CM, female is 80cm; 4. No lipid and hypoglycemic drugs were used during the screening; 5. LDL-c>3.37 mmol/L and TC>5.18 mmol/L; or TG>1.7 mmol/L; or HDL-c5.18 mmol/L and TG>1.7 mmol/L; 6. Willing to maintain a stable diet and physical activity level during the study period.

Exclusion criteria

Exclusion criteria: 1. TG > 5.65mmol/L, with target organ damage caused by hyperlipemia, secondary hyperlipemia, homozygous hyperlipidemia. HbA1c > 8.5%, or ALT and / or AST greater than 3 times, or CREA > 1.5; 2. pregnancy; 3. Antibiotics and microecological agents (probiotics, probiotics, etc.) and PPI inhibitors were taken within 4 weeks before the specimens were retained; 4. Patients with digestive system diseases (IBS), gastrointestinal dysfunction, inflammatory bowel diseases (such as ulcerative colitis and Crohn's disease), colon and rectal cancer) are treated with any other known or potential lipid-regulating drugs, herbal preparations or dietary supplements (such as whey protein, beta-glucan and polyphenols); 5. Allergy to research products.

Design outcomes

Primary

MeasureTime frame
triglyceride;total cholesterol;low density lipoprotein cholesterol;high density lipoprotein cholesterol;

Secondary

MeasureTime frame
visceral fat weight;??;???;glycosylated hemoglobin,;intestinal flora structure;bile acid structure spectrum;

Countries

China

Contacts

Public ContactPan Ruirong

Affiliated Hospital of Jiangsu University

ruirong123@163.com+86 15896382511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026